<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <caption class="caption">
  <label class="label">Table 2</label>
  <p class="p" xmlns="">Half maximal inhibitory concentration (IC 
   <sub class="sub">50</sub>) values of the cytotoxic activity of the essential oil (EO) from the leaves of 
   <italic class="italic">Croton matourensis.</italic>
  </p>
 </caption>
 <thead class="thead">
  <tr class="tr" xmlns="">
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Cell Lines</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Origin</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Histological Type</th>
   <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" class="th">IC 
    <sub class="sub">50</sub> in µg/mL 
   </th>
  </tr>
  <tr class="tr" xmlns="">
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th"> </th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th"> </th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th"> </th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">EO</th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">DOX</th>
  </tr>
 </thead>
 <tbody class="tbody">
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" rowspan="1" colspan="1" class="td">
    <bold class="bold">Cancer cells</bold>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" rowspan="1" colspan="1" class="td">MCF-7</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Breast adenocarcinoma</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">23.3 
    <break class="break"/>18.2–29.7 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">0.3 
    <break class="break"/>0.2–0.4 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" rowspan="1" colspan="1" class="td">HCT116</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Colon carcinoma</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">28.9 
    <break class="break"/>22.1–37.8 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">0.1 
    <break class="break"/>0.1–0.2 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" rowspan="1" colspan="1" class="td">HepG2</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Hepatocellular carcinoma</td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">28.5 
    <break class="break"/>17.1–37.3 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td">0.03 
    <break class="break"/>0.01–0.2 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">HL-60</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Promyelocytic leukemia</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">17.8 
    <break class="break"/>14.6–21.7 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">0.04 
    <break class="break"/>0.02–0.08 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" rowspan="1" colspan="1" class="td">
    <bold class="bold">Non-cancer cell</bold>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">MRC-5</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Human</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Lung fibroblast</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">25.8 
    <break class="break"/>22.0–30.4 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">0.2 
    <break class="break"/>0.1–0.5 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p charset="fn" class="fn">
   <p class="p" xmlns="">Data are presented as IC 
    <sub class="sub">50</sub> values, in μg/mL, with respective 95% confidence interval obtained by nonlinear regression from at least three independent experiments performed in duplicate, measured by Alamar blue assay after 72 h of treatment. Doxorubicin (DOX) was used as the positive control. 
   </p>
  </p>
 </tfoot>
</table>
